GDF15 and urinary bladder carcinoma: CAPE stimulated the GDF15 secretion, while being co-treated with rhTGFβ blocked the activation of CAPE on GDF15 secretion from bladder carcinoma, RT-4 and HT1376, cells (Figure 4E).